<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<base href="AHE%203/14/24">
<title>A1825 1R</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 6 4 5 2 3 4;}
@font-face
	{font-family:Albertus;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:AlbertusExtraBold;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.PrefileFronterTitle, li.PrefileFronterTitle, div.PrefileFronterTitle
	{mso-style-name:PrefileFronterTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.StylePrefileFronterTitleLeft, li.StylePrefileFronterTitleLeft, div.StylePrefileFronterTitleLeft
	{mso-style-name:"Style PrefileFronterTitle + Left";
	margin-top:0in;
	margin-right:-.2in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times",serif;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.Superscript
	{mso-style-name:Superscript;
	font-family:"Albertus",sans-serif;
	font-weight:bold;
	vertical-align:super;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.amendfooter, li.amendfooter, div.amendfooter
	{mso-style-name:amendfooter;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.5in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.2in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuReprint><a name=bpuFrontPg></a>[First Reprint]</p>

<p class=bpuBill>ASSEMBLY, No. 1825 </p>

<p class=bpuWpGraphic></p>

<p class=bpuState>STATE OF NEW JERSEY</p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Assemblyman  HERB CONAWAY, JR.</p>

<p class=bpuSponsor>District 7 (Burlington)</p>

<p class=bpuSponsor>Assemblyman  ANTHONY S. VERRELLI</p>

<p class=bpuSponsor>District 15 (Hunterdon and Mercer)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>Co-Sponsored by:</p>

<p class=bpuSponsor>Assemblywomen Murphy, Swain, Assemblyman Tully,
Assemblywoman Speight, Assemblymen Danielsen, Karabinchak, Assemblywomen
Quijano, Lampitt, Lopez, N.Munoz, Tucker, Reynolds-Jackson, Dunn, Assemblymen
Stanley, Sauickie, Clifton, Assemblywomen Haider, Swift, Assemblyman DeAngelo,
Assemblywoman Carter, Assemblymen Bergen, Guardian, Azzariti Jr. and
Assemblywoman Matsikoudis</p>

<p class=MsoNormal>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Establishes certain guidelines for health insurance
carriers concerning step therapy protocols. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     As reported by the Assembly Health Committee on March
14, 2024, with amendments.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:10.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> </span>concerning health insurance and supplementing
Title 26 of the Revised Statutes.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     1.    The Legislature finds
and declares that:</p>

<p class=MsoNormal style='line-height:150%'>     a.     Health insurance plans
are increasing the use of step therapy protocols that require patients to try
one or more prescription drugs before coverage is provided for a drug selected
by the patients health care provider.</p>

<p class=MsoNormal style='line-height:150%'>     b.    Step therapy protocols,
if based on well-developed scientific standards and administered in a flexible
manner that takes into account the individual needs of patients, can play an
important role in controlling health care costs.</p>

<p class=MsoNormal style='line-height:150%'>     c.     In some cases,
requiring a patient to follow a step therapy protocol may have adverse and even
dangerous consequences for the patient who may either not realize a benefit
from taking a prescription drug or may suffer harm from taking an inappropriate
drug.</p>

<p class=MsoNormal style='line-height:150%'>     d.    Without uniform policies
in the State for step therapy protocols, all patients may not receive the
equivalent or most appropriate treatment. </p>

<p class=MsoNormal style='line-height:150%'>     e.     It is imperative that
step therapy protocols in the State preserve the heath care providers right to
make treatment decisions in the best interest of the patient.</p>

<p class=MsoNormal style='line-height:150%'>     f.     The Legislature
declares, therefore, that it is a matter of public interest that health
insurance carriers be required to base step therapy protocols on appropriate
clinical practice guidelines or published peer-reviewed data developed by
independent experts with knowledge of the condition or conditions under
consideration; that patients be exempt from step therapy protocols when those
protocols are inappropriate or otherwise not in the best interest of the
patients; and that patients have access to a fair, transparent and independent
process for requesting an exception to a step therapy protocol when the
patients physician deems appropriate.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2.    As used in this act:</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Carrier&quot; means an
insurance company, health service corporation, hospital service corporation,
medical service corporation, or health maintenance organization authorized to
issue health benefits plans in this State.</p>

<p class=MsoNormal style='line-height:150%'>     Clinical practice guidelines
means a systematically developed statement to assist decision making by health
care providers and patient decisions about appropriate healthcare for specific
clinical circumstances and conditions.</p>

<p class=MsoNormal style='line-height:150%'>     Clinical review criteria
means the written screening procedures, decision abstracts, clinical protocols
and practice guidelines used by a carrier or utilization review organization to
determine the medical necessity and appropriateness of health care services. </p>

<p class=MsoNormal style='line-height:150%'>     Commissioner means the
Commissioner of Banking and Insurance.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Covered person&quot;
means a person on whose behalf a carrier offering the plan is obligated to pay
benefits or provide services pursuant to the health benefits plan.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Health benefits
plan&quot; means a benefits plan which pays or provides hospital and medical
expense benefits for covered services, and is delivered or issued for delivery in
this State by or through a carrier.  Health benefits plan includes, but is not
limited to, Medicare supplement coverage and risk contracts to the extent not
otherwise prohibited by federal law.  For the purposes of this act, health
benefits plan shall not include the following plans, policies, or contracts: 
accident only, credit, disability, long-term care, CHAMPUS supplement coverage,
coverage arising out of a workers' compensation or similar law, automobile
medical payment insurance, personal injury protection insurance issued pursuant
to P.L.1972, c.70 (C.39:6A-1 et seq.), or hospital confinement indemnity
coverage.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Health care
provider&quot; means an individual or entity which, acting within the scope of
its licensure or certification, provides a covered service defined by the
health benefits plan.  Health care provider includes, but is not limited to, a
physician and other health care professionals licensed pursuant to Title 45 of
the Revised Statutes, and a hospital and other health care facilities licensed
pursuant to Title 26 of the Revised Statutes.</p>

<p class=MsoNormal style='line-height:150%'>     Medically necessary means
health services and supplies that, under the applicable standard of care, are
appropriate:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   to improve or preserve
health, life, or function;  </p>

<p class=MsoNormal style='line-height:150%'>     (2)   to slow the deterioration
of health, life, or function; or </p>

<p class=MsoNormal style='line-height:150%'>     (3)   for the early screening,
prevention, evaluation, diagnosis or treatment of a disease, condition, illness
or injury.</p>

<p class=MsoNormal style='line-height:150%'>     Step therapy exception means
the overriding of a step therapy protocol in favor of immediate coverage of the
health care providers selected prescription drug. </p>

<p class=MsoNormal style='line-height:150%'>     Step therapy protocol means
a protocol, policy, or program that establishes the specific sequence in which
prescription drugs for a specified medical condition, and medically appropriate
for a particular patient, are required to be administered in order to be
covered by a health benefits plan. </p>

<p class=MsoNormal style='line-height:150%'>     Utilization review
organization means an entity that conducts utilization review, other than a
carrier performing utilization review for its own health benefit plans.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.    a.  Clinical review
criteria used to establish a step therapy protocol shall be based on clinical
practice guidelines that: </p>

<p class=MsoNormal style='line-height:150%'>     (1)   recommend that the
prescription drugs be taken in the specific sequence required by the step therapy
protocol;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   are developed and
endorsed by a multidisciplinary panel of experts that manages conflicts of
interest among the members of the writing and review groups by:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   requiring members to
disclose any potential conflict of interests with entities, including carriers
and pharmaceutical manufacturers, and recuse themselves from voting if they
have a conflict of interest; </p>

<p class=MsoNormal style='line-height:150%'>     (b)   using a methodologist to
work with writing groups to provide objectivity in data analysis and ranking of
evidence through the preparation of evidence tables and facilitating consensus;
and</p>

<p class=MsoNormal style='line-height:150%'>     (c)   offering opportunities
for public review and comments; and</p>

<p class=MsoNormal style='line-height:150%'>     (3)   are based on high
quality studies, research, and medical practice;</p>

<p class=MsoNormal style='line-height:150%'>     (4)   are created by an
explicit and transparent process that:</p>

<p class=MsoNormal style='line-height:150%'>     (a)   minimizes biases and
conflicts of interest;</p>

<p class=MsoNormal style='line-height:150%'>     (b)   explains the
relationship between treatment options and outcomes;</p>

<p class=MsoNormal style='line-height:150%'>     (c)   rates the quality of the
evidence supporting recommendations; and</p>

<p class=MsoNormal style='line-height:150%'>     (d)   considers relevant
patient subgroups and preferences; and</p>

<p class=MsoNormal style='line-height:150%'>     (5)   are continually updated
through a review of new evidence, research and newly developed treatments.</p>

<p class=MsoNormal style='line-height:150%'>      b.   In the absence of
clinical guidelines that meet the requirements in subsection a. of this
section, peer-reviewed publications may be substituted. </p>

<p class=MsoNormal style='line-height:150%'>      c.    When establishing a
step therapy protocol, a utilization review agent shall also consider the needs
of atypical patient populations and diagnoses when establishing clinical review
criteria.</p>

<p class=MsoNormal style='line-height:150%'>      d.   A carrier shall:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   upon written request,
provide specific written clinical review criteria relating to a particular
condition or disease, including clinical review criteria relating to a step
therapy protocol exception determination; and</p>

<p class=MsoNormal style='line-height:150%'>     (2)   make available the
clinical review criteria and other clinical information on its internet website
and to a health care professional on behalf of an insured person upon written
request.</p>

<p class=MsoNormal style='line-height:150%'>      e.    This section shall not
be construed to require carriers or the State to establish a new entity to
develop clinical review criteria used for step therapy protocols.</p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      4.   Notwithstanding
the provisions of any law, rule, or regulation to the contrary:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>       a.  When
coverage of a prescription drug for the treatment of any medical condition is
restricted for use by a carrier or utilization review organization pursuant to
a step therapy protocol, the carrier or utilization review organization shall
provide the covered person and prescribing practitioner a clear, readily
accessible, and convenient process to request a step therapy exception. A
carrier or utilization review organization may use its existing medical
exceptions process to satisfy this requirement. An explanation of the process
shall be made available on the carrier or utilization review organizations
website.  A carrier or utilization review organization shall disclose all rules
and criteria related to the step therapy protocol upon request to all
prescribing practitioners, including the specific information and documentation
required to be submitted by a prescribing practitioner or patient for an
exception request to be complete.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>       b.  A
step therapy exception shall be granted if: </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (1)  the
required prescription drug is contraindicated or is likely to cause an adverse
reaction or physical or mental harm to the patient;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2)  the
required prescription drug is expected to be ineffective based on the known
clinical characteristics of the patient and the known characteristics of the
prescription drug regimen;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3)  the
patient has tried the required prescription drug or another prescription drug
in the same pharmacologic class or with the same mechanism of action and the
prescription drug was discontinued due to lack of efficacy or effectiveness,
diminished effect, or an adverse event; </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (4)  the
required prescription drug is not in the best interest of the patient, based on
medical necessity; or</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (5)  the
patient is stable on a prescription drug selected by their health care provider
for the medical condition under consideration. </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>       c.  When
a step therapy exception is granted, the carrier or utilization review
organization shall authorize coverage for the prescription drug prescribed by
the patients treating health care provider.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>       d.  Any
step therapy exception shall be eligible for appeal by a covered person.  The
carrier or utilization review organization shall grant or deny a step therapy
exception request or an appeal of a step therapy exception request within 72
hours of receipt of the request or appeal. In cases where exigent circumstances
exist, the carrier or utilization review organization shall respond within 24
hours of receipt.  If a request for a step therapy exception is incomplete or
if additional clinically relevant information is required, the carrier or
utilization review organization shall notify the prescribing practitioner
within 72 hours of submission, or 24 hours in exigent circumstances, what
additional or clinically relevant information is required in order to approve
or deny the step therapy exception request or appeal pursuant to the criteria
disclosed pursuant to subsection a. of this section.  Once the requested
information is submitted, the applicable time period to grant or deny a step
therapy exception request or appeal shall apply.  If a response by a carrier or
utilization review organization is not received within the time allotted, the
exception or appeal shall be deemed granted.  In the event of a denial, the
carrier or utilization review organization shall inform the patient of the
appeal process.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>       e.  Any
step therapy exception pursuant to this section shall be eligible for appeal by
a covered person.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>       f.   This
section shall not be construed to prevent:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (1)  a
carrier or utilization review organization from requiring a patient to try an
AB-rated generic equivalent </span><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u><span
style='letter-spacing:0pt'>, biosimilar,</span></u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
style='letter-spacing:0pt'> or interchangeable biological product prior to
providing coverage for the equivalent branded prescription drug;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2)  a
carrier or utilization review organization from requiring a pharmacist to
effect substitutions of prescription drugs consistent with the laws of this State;
or</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3)  a
health care provider from prescribing a prescription drug that is determined to
be medically appropriate.</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>      5.   Annually, a carrier or
utilization review organization shall report to the commissioner, in a format
prescribed by the commissioner: </p>

<p class=MsoNormal style='line-height:150%'>      a.    the number of step
therapy exception requests received, by reason for the exception;</p>

<p class=MsoNormal style='line-height:150%'>      b.   the type of health care
providers or the medical specialties of the health care providers submitting
step therapy exception requests; </p>

<p class=MsoNormal style='line-height:150%'>      c.    the number of step
therapy exception requests that were denied, by reason for the exception, and
the reasons for the denials; </p>

<p class=MsoNormal style='line-height:150%'>      d.   the number of step
therapy exception requests that were approved, by reason for the exception; </p>

<p class=MsoNormal style='line-height:150%'>      e.    the number of step
therapy exception requests that were initially denied and then appealed, by
reason for the exception;</p>

<p class=MsoNormal style='line-height:150%'>      f.    the number of step
therapy exception that were initially denied and then subsequently reversed by
internal appeals or external reviews, by reason for the exception; and </p>

<p class=MsoNormal style='line-height:150%'>      g.   the medical conditions
for which patients are granted exceptions due to the likelihood that switching
from the prescription drug will likely cause an adverse reaction by or physical
or mental harm to the insured.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>      6.   The commissioner shall
adopt, pursuant to the Administrative Procedure Act P.L.1968, c.410
(C.52:14B-1&nbsp;et&nbsp;seq.),&nbsp;rules and regulations to effectuate the
purposes of this&nbsp;act.<br clear=all style='page-break-before:always'>
</p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      7.   This
act shall take effect on the 60th day after enactment and apply to all
contracts and policies delivered, issued, executed, or renewed on or after </span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>January 1, 2021</span><b><span style='font-family:
"Albertus Extra Bold",sans-serif'>]</span></b><span style='letter-spacing:0pt'>
<u>July 1, 2024</u></span><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
style='letter-spacing:0pt'>.</span></p>

</div>

</body>

</html>
